The need to swab the noses of pregnant women and newborns for the presence of methicillin-resistant Staphylococcus aureus (MRSA) may be unfounded, according to a Vanderbilt study now available online and published in the May issue of Pediatrics.
Â
The studys senior author, Buddy Creech, M.D., MPH, assistant professor of Pediatrics, said it is often feared that mothers carrying MRSA may risk transmitting an infection to their newborn babies, but Vanderbilt Pediatric Infectious Diseases researchers found that babies rarely became ill from MRSA infections, despite frequently carrying the germ.
Â
Describing the timing and mode of transmission is important, since the most critical finding in this research is that babies are very commonly exposed to MRSA in early infancy, often with strains that aren't likely to cause disease, Creech says.
Â
The study enrolled more than 500 pregnant women in Nashville and Memphis. Nasal and vaginal swabs were collected and tested for the presence of bacteria at regular intervals, including at the time of delivery. Babies were swabbed right after birth and at 2 and 4 months of age.
Results show little vertical transmission of MRSA from mother to child, Creech said, but babies did closely match their mothers carrier status by 2 months of age. This suggests a mother who carries S. aureus bacteria in her nose will give it to her baby and her baby will become colonized from close contact within six to eight weeks after birth, which is called horizontal transmission.
Â
Labs were finding a substantial amount of MRSA. Even in our study we found 20 percent of pregnant women will have it, as will 20 percent of babies at eight weeks, Creech says. But there is tremendous anxiety about what that means and, for physicians, what do you do?
We dont want to overreact to carriage when incidence of disease is low. A lot of babies are colonized. A lot. Twenty percent at 2 months of age is the highest rate weve ever seen, but in our study only two babies got disease, Creech says.
Â
Creech says, at this time, the best action when MRSA colonization is detected in a pregnant woman may be no action at all.
The next step in research is to determine if mother-to-child transmission of MRSA in infancy might provide benefits, like greater protection against more serious MRSA illnesses later in life.
Â
The studys first author is Natalia Jimenez-Truque, MQC, MSCI, Epidemiology graduate student in Pediatric Infectious Diseases.
Â
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.